Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer

businesswire

Kairos Pharma Announces Virtual KOL Event to Provide Perspectives on ENV105 Interim Efficacy Results in Advanced Prostate Cancer – NEWSnet – News… as it used to be

More Press Releases

May 26, 2026

Volatus Aerospace Selected to Advance to Next Phase of U.S. Drone Dominance Program

May 26, 2026

MIND CTI Announces Appointment of Monica Iancu as Interim Chief Executive Officer

May 26, 2026

Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering

May 26, 2026

All In FutureTech Alliance Inc. Announces Filing of Form 8-K for HyalRoute Acquisition Transaction and Releases HyalRoute Business Overview and Financial Data